Literature DB >> 32279434

Precautions in ophthalmic practice in a hospital with the risk of COVID-19: experience from China.

Xiang Ma1, Jingrong Lin1, Shifeng Fang1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32279434      PMCID: PMC7262081          DOI: 10.1111/aos.14436

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


× No keyword cloud information.
Editor, The coronavirus disease (COVID‐19) was first found in December, 2019 in Wuhan, China. It swept through China and worldwide. It can cause severe acute respiratory infection with an incubation period of 1–14 days (Chen et al. 2020; Huang et al. 2020), and mainly spread by respiratory droplets, although spreading by discharges, faeces, aerosol, conjunctiva, etc. was also suspected (Li et al. 2020). Ophthalmologists often contact with patients closely and are exposed to risk of cross infection. It is important that the ophthalmologists get acquaintance with strategy of protection during clinical practice. Personal protection of ophthalmologists: since the safe distance of droplets transmission is ≥1.5 m, we suggest ophthalmologists taking different levels of protection according to clinical practices (Table 1). Management of hand hygiene should always be strictly complied with.
Table 1

Personal protective equipments

Level of riskProceduresProtective equipments
Low riskIndirect contact with suspected patients, consultation, inspection without examinations or performance proceduresGown, surgical mask, disposable cap
Moderate riskExamination with slit lamp, funduscope, gonioscope, ophthalmic ultrasound, UBM, fluorescence angiography, puncture, injection and laser therapyWater repellent gown, barrier apparel, surgical mask or N95 respirator, disposable cap, gloves, goggle or face shield, shoe covers
High riskSpecimen collection from the eye, intraocular surgeryWater repellent gown, barrier apparel, N95 respirator, disposable cap, double gloves, goggle or face shield, shoe covers
Personal protective equipments Disinfection of inspection equipments: SARS‐CoV‐2 is sensitive to UV and heat. It can be inactivated at 56°C for 30 min or by lipid solvent such as ether, 75% ethanol, chlorine disinfectant, peracetic acid and chloroform. A shield plate should be installed on the slit lamp to prevent droplets transmission. Slit lamp, automatic refractor, corneal topography, OCT, fundus camera and fluorescein angiography should be cleaned with 75% ethanol or 3% hydrogen peroxide tampon. Appliances directly contacting with patients’ ocular surface, such as Goldmann applanation tonometer, gonioscope, specular microscope, ultrasound probe and UBM probe, should be soaked by 2% alkaline glutaraldehyde, washed by flowing water and then cleaned by 75% ethanol or 3% hydrogen peroxide tampon (Rutala 1996). Since microaerosol might be formed due to tear film dehiscence, the non‐contact ‘air‐puff’ tonometry should be placed in ventilated place, and the probe should be well disinfected every time after use (Britt et al. 1991). Outpatient care: a triage system should be run by experienced nurses. The nurse should measure body temperature and inquire contact history of all the patients. Patients with fever or contact history of COVID‐19 patients within 14 days were guided to the fever clinic for further evaluations. Only patients without fever or contact history are allowed to enter the eye clinic. The patients should put on masks as well. The clinic should be well ventilated, disinfected with UV of 250–270 nm for 30–60 min. The staff are encouraged to follow the precautions listed above and discard gloves, wash or alcohol‐rub the hands and then put on new gloves in‐between case. In‐patient care: during the epidemic period, diseases admitted to the eye ward should be arranged accordingly. Only ocular emergencies such as eye traumas, acute glaucoma, rhegmatogenous retinal detachment and central retinal artery occlusion are considered for admission. The patients of new admission should be arranged one person in one room and be monitored attentively. Ophthalmic operation care: non‐urgent interventions such as barrier laser, YAG: Nd laser capsulotomy, pan‐retinal photocoagulation, incision and curettage should be suspended or performed only when necessary. While ruptured eyeball, intraocular foreign body, acute glaucoma, rheugmatogenous retinal detachment and central retinal artery occlusion could be arranged for operation. Operation should be performed in well‐ventilated or negative pressure environment. The operating room is regarded as a high‐risk area, and universal precaution measures with barrier apparels should be strictly taken. The SARS‐CoV‐2 is one of the viruses against which we need protection in ophthalmic setting. The measures we mentioned here may help protect from COVID‐19 and reduce the risk of its further spreading within hospital.
  5 in total

1.  Microaerosol formation in noncontact 'air-puff' tonometry.

Authors:  J M Britt; B C Clifton; H S Barnebey; R P Mills
Journal:  Arch Ophthalmol       Date:  1991-02

Review 2.  APIC guideline for selection and use of disinfectants. 1994, 1995, and 1996 APIC Guidelines Committee. Association for Professionals in Infection Control and Epidemiology, Inc.

Authors:  W A Rutala
Journal:  Am J Infect Control       Date:  1996-08       Impact factor: 2.918

3.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

4.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

5.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

Authors:  Nanshan Chen; Min Zhou; Xuan Dong; Jieming Qu; Fengyun Gong; Yang Han; Yang Qiu; Jingli Wang; Ying Liu; Yuan Wei; Jia'an Xia; Ting Yu; Xinxin Zhang; Li Zhang
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

  5 in total
  2 in total

1.  The Impact of COVID-19 on Intravitreal Injection Compliance.

Authors:  Lauren M Wasser; Yishay Weill; Koby Brosh; Itay Magal; Michael Potter; Israel Strassman; Evgeny Gelman; Meni Koslowsky; David Zadok; Joel Hanhart
Journal:  SN Compr Clin Med       Date:  2020-10-28

2.  Telemedicine comes of age during coronavirus disease 2019 (COVID-19): An international survey of oculoplastic surgeons.

Authors:  Elishai Assayag; Maria Tsessler; Lauren M Wasser; Elena Drabkin; Ehud Reich; Yishay Weill; David Zadok; Akshay Gopinathan Nair; Aleza Andron
Journal:  Eur J Ophthalmol       Date:  2020-10-17       Impact factor: 2.597

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.